Company Filing History:
Years Active: 2002-2014
Title: Konrad Beyreuther: Innovator in Neurodegenerative Research
Introduction
Konrad Beyreuther is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of neurodegenerative disorders through his innovative research and patented inventions. With a total of 3 patents, Beyreuther's work focuses on understanding and addressing critical health issues.
Latest Patents
One of his latest patents is titled "Crystal form of the amyloid precursor protein intracellular domain (AICD) in complex with human FE65-PTB2." This invention relates to a three-dimensional structure of the intracellular domain of human amyloid precursor protein (APP695) in complex with human Fe65-PTB2. The patent outlines methods and uses of this structure for identifying ligands that modify the interaction between AICD and Fe65-PTB2. Additionally, it discusses pharmaceutical compositions containing these identified ligands for the prevention or treatment of neurodegenerative disorders.
Another significant patent by Beyreuther is "Customized micro-array construction and its use for target molecule detection." This invention presents a method for detecting and quantifying different sets of target molecules that may be present simultaneously in a biological sample. The method utilizes a microarray on a solid support surface, comprising various capture molecules located in different areas of the surface.
Career Highlights
Throughout his career, Konrad Beyreuther has worked with notable organizations, including the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts and Eppendorf AG. His work has been instrumental in advancing research in the field of neurodegenerative diseases.
Collaborations
Beyreuther has collaborated with esteemed colleagues such as Manfred Wiessler and Lars-Erik Peters. These partnerships have further enriched his research and contributed to the development of innovative solutions in his field.
Conclusion
Konrad Beyreuther's contributions to neurodegenerative research through his patents and collaborations highlight his role as a key innovator in the scientific community. His work continues to pave the way for advancements in understanding and treating complex health issues.